Successful unrelated cord blood transplantation in a 7-year-old boy with Evans syndrome refractory to immunosuppression and double autologous stem cell transplantation

European Journal of Haematology
Christian UrbanAndrea Moser

Abstract

Evans syndrome is an autoimmunopathy characterized by thrombocytopenia and autoimmune hemolytic anemia with poor response to immunosuppression. A 2-yr-old boy with Evans syndrome showed only short-lasting responses to immunosuppressive treatment including double autologous peripheral stem cell transplantation (SCT). Intracranial bleeding required emergency splenectomy and external ventricular drainage. Unrelated umbilical cord blood was given following conditioning with busulfan, thiotepa, etoposide and antithymocyte globulin. One year after SCT the patient shows stable blood counts without immunosuppression. This is the first child reported with Evans syndrome successfully treated by means of unrelated cord blood transplantation.

References

Jan 1, 1988·The American Journal of Pediatric Hematology/oncology·W C Wang
Oct 27, 1997·Bone Marrow Transplantation·E RaetzR H Adams
Nov 26, 1997·Archives of Disease in Childhood·S SavaşanY Ravindranath
Jan 10, 2002·Bone Marrow Transplantation·Y OyamaR K Burt
Jul 2, 2002·Blood·Victor M MoyoRobert A Brodsky
Jan 1, 1951·A.M.A. Archives of Internal Medicine·R S EVANSC LIU
Jun 8, 2004·British Journal of Haematology·J R PasswegUNKNOWN Autoimmune Disease Working Party of the EBMT
Aug 26, 2004·British Journal of Haematology·Uday Popat, Robert Krance
Oct 16, 2004·Pediatric Blood & Cancer·Yaddanapudi Ravindranath
Feb 3, 2005·British Journal of Haematology·R E HoughN M Wulffraat
Jun 3, 2005·Nature·Megan Sykes, Boris Nikolic

❮ Previous
Next ❯

Citations

Dec 3, 2015·British Journal of Haematology·Maurizio Miano
Nov 11, 2006·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Andres PintoFaizan Alawi
Sep 15, 2009·Transfusion Medicine·J A SnowdenS M Watt
Dec 6, 2008·Hematology·Kajal Kiran DhingraNaresh Gupta
Sep 26, 2015·Seminars in Hematology·Wilma Barcellini
Dec 21, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marco RabusinUNKNOWN European Group for Blood and Marrow Transplantation Autoimmune Diseases and Paediatric Disease Working Parties
Aug 24, 2007·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·S B RosaP Pranke
Oct 30, 2008·Autoimmunity·Alberto M Marmont, Riccardo Saccardi
Oct 23, 2018·Technology in Cancer Research & Treatment·Yousef M HawsawiAtif Abdulwahab A Oyouni
Oct 10, 2018·Journal of Pediatric Hematology/oncology·Tristan KnightMichael U Callaghan
May 19, 2010·Expert Review of Clinical Immunology·Martin BeneschJakob Passweg
Jan 19, 2011·Journal of Experimental & Clinical Cancer Research : CR·Daniele LodiBeniamino Palmieri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.